Skip to main content
CMEducation Resources ScrollCall
  • menu
  • menu
  • person
  • Search
  • Specialty
  • Cardiology chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • Diabetes chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • Specialty Program
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Cytokine Immunotherapy chevron_right
  • Hypothyroidism chevron_right
  • Specialty Program
  • Parkinson's Diseasechevron_right
  • Specialty
  • Cancer chevron_right

  • Specialty Program
  • Cytokine Immunotherapy chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Pain Management chevron_right
  • Specialty
  • Primary Care chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Parkinson's Diseasechevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • Specialty
  • Dermatology chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Specialty
  • Biologicschevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Biosimilars for RA chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • MAC Lung Disease chevron_right

  • Specialty Program
  • MAC Lung Disease chevron_right
    • close
    CMEducation Resources iQ&A
    • person
    • Home
    • Specialtieschevron_right
      • chevron_leftTopics
      • Cardiology
      • Diabetes
      • Endocrinology
      • Neurology
      • Cancer
      • Primary Care
      • Dermatology
      • Biologics
      • MAC Lung Disease
    • Submit A Question
    close

    Peter Benn PhD, DS

    Peter Benn PhD, DS

    Professor
    Department of Genetics and Genome Sciences
    University of Connecticut Health Center
    Farmington, CT


    Related Videos

    What is the rationale for deploying SNP-based NIPT in larger swaths of the population, especially in lower risk populations? Do studies economic and clinical studies suggest there is value using these tests in low risk patients? Video

    What is the rationale for deploying SNP-based NIPT in larger swaths of the population, especially in lower risk populations? Do studies economic and clinical studies suggest there is value using these tests in low risk patients?

    What is the rationale for deploying SNP-based NIPT in larger swaths of the population, especially in lower risk populations? Do studies economic and clinical studies suggest there is value using these tests in low risk patients?

    What are the ethics—on a societal and individual level—of NIPT screening, and why is it critical that we screen for these fetal abnormalities? Video

    What are the ethics—on a societal and individual level—of NIPT screening, and why is it critical that we screen for these fetal abnormalities?

    What are the ethics—on a societal and individual level—of NIPT screening, and why is it critical that we screen for these fetal abnormalities?

    Why is the SNP-based approach preferred for screening for microdeletions? Video

    Why is the SNP-based approach preferred for screening for microdeletions?

    Why is the SNP-based approach preferred for screening for microdeletions?

    How does the incidence of 22q11.2 deletion compare with Down syndrome in terms of incidence at various maternal ages? What is the rationale for screening for this deletion? Video

    How does the incidence of 22q11.2 deletion compare with Down syndrome in terms of incidence at various maternal ages? What is the rationale for screening for this deletion?

    How does the incidence of 22q11.2 deletion compare with Down syndrome in terms of incidence at various maternal ages? What is the rationale for screening for this deletion?

    What are the advantages of SNP-based technology compared with the counting method when utilizing cell-free DNA to identify women at increased risk to be carrying a fetus with a microdeletion syndrome such as 22q11.1? Which test has the most robust data? Video

    What are the advantages of SNP-based technology compared with the counting method when utilizing cell-free DNA to identify women at increased risk to be carrying a fetus with a microdeletion syndrome such as 22q11.1? Which test has the most robust data?

    What are the advantages of SNP-based technology compared with the counting method when utilizing cell-free DNA to identify women at increased risk to be carrying a fetus with a microdeletion syndrome such as 22q11.1? Which test has the most robust data?

    What are microdeletions and what is the rationale for offering screening for these conditions using NIPT? Especially to detect for with a microdeletion syndrome such as 22q11.1? Video

    What are microdeletions and what is the rationale for offering screening for these conditions using NIPT? Especially to detect for with a microdeletion syndrome such as 22q11.1?

    What are microdeletions and what is the rationale for offering screening for these conditions using NIPT? Especially to detect for with a microdeletion syndrome such as 22q11.1?

    Do companies that provide NIPT tests also report results of uncertain significance? What are the clinical implications of this? Video

    Do companies that provide NIPT tests also report results of uncertain significance? What are the clinical implications of this?

    Do companies that provide NIPT tests also report results of uncertain significance? What are the clinical implications of this?

    How does each of the NIPT testing products meet the laboratory guidelines for NIPT set forth by ACMG and ACOG/SMFM, especially reporting guidelines such as PPV and NPV? Are reports from any particular company consistent with the recently issued ACMG guidelines? Video

    How does each of the NIPT testing products meet the laboratory guidelines for NIPT set forth by ACMG and ACOG/SMFM, especially reporting guidelines such as PPV and NPV? Are reports from any particular company consistent with the recently issued ACMG guidelines?

    How does each of the NIPT testing products meet the laboratory guidelines for NIPT set forth by ACMG and ACOG/SMFM, especially reporting guidelines such as PPV and NPV? Are reports from any particular company consistent with the recently ...

    Which of the NIPT reports—SNP tests, by specific laboratories—are known to have the advantage of having high positive predictive values (PPV)? Video

    Which of the NIPT reports—SNP tests, by specific laboratories—are known to have the advantage of having high positive predictive values (PPV)?

    Which of the NIPT reports—SNP tests, by specific laboratories—are known to have the advantage of having high positive predictive values (PPV)?

    Disclaimer:
    Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
    Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
    Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
    Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

    Clinical Webcasts®

    Powered by BroadcastMedBROADCASTMED